Dr Bhagteshwar Singh

Research Associate

I am a senior trainee in Infectious Diseases, Internal Medicine & Tropical Medicine, and an early career researcher. My work focuses on improving the care for people with infections of global importance through clinical and health systems research, evidence synthesis, and guidelines.

I completed my undergraduate and core postgraduate medical training in and around Manchester, moving to Liverpool in 2014. Since 2018 I have been the lead fellow for the multi-country NIHR Global Health Research Group on Acute Brain Infections and then the MRC/UKRI/GECO funded COVID-associated neurological disease programme in India, Brazil and Malawi. I was based primarily at the Christian Medical College (CMC), Vellore, India from 2018 to 2023. I am currently gaining clinical experience in tropical medicine: having spent 6 months at CMC Vellore again, I am now in the Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.

Research 

Brain Infections Global (NIHR Global Health Research Group on Acute Brain Infections). 2018-2022; £2M; NIHR (UK). Lead Research Fellow. Multicentre complex intervention and diagnostic study. 

COVID-19 Neurological Disease. 2020-2023; £860k; UKRI/DHSC/MRC Global Effort on COVID-19 (GECO). Lead Fellow & Co-applicant. Individual patient data meta-analysis & prospective clinical study. 

COVID Management Guidelines India Group. 2021-2022; READ-It (DFID/FCDO grant). Core & Methodology Committees; Antiviral Expert Working Group; Co-Lead, Evidence Synthesis Team. 

EAN-ESCMID Guidelines on Infectious Encephalitis. 2021-2022. Methodologist.
India Brain Infections Guidelines Group. 2023 to present. Core & Methodology Committee Member; Co-Lead, Evidence Synthesis Team. 

Memberships and affiliations

Co-investigator, Centre for Guideline Development, Christian Medical College, Vellore, India.

Clinical Research Fellow, Department of Clinical Infection Microbiology & Immunology, Institute of Infection Veterinary & Ecological Sciences, University of Liverpool, UK.

Case Management Expert Consultant (including full- and part-time roles), South-East Asia Region Office (SEARO), WHO Emergencies Programme.

Selected publications

  • Singh B, Alexander H, Tharyan P, et al. The COVID guidelines India project: A rapid living evidence synthesis during a pandemic in a LMIC setting. Clinical Epidemiology and Global Health. 2024;101548 [in press]. doi: 10.1016/j.cegh.2024.101548.

    Rupali P, Singh B, Princy NG, et al. The India brain infections guidelines project: Global evidence for local application. Clinical Epidemiology and Global Health. 2024;27:101560. doi: 10.1016/j.cegh.2024.101548.

    Korula P, …, Singh B, et al. Favipiravir for treating COVID-19. Cochrane Database Syst Rev. 2024;2:CD015219. doi: 10.1002/14651858.CD015219.pub2.

    Damodar T, Singh B, Prabhu N, et al. Association of Scrub Typhus in Children with Acute Encephalitis Syndrome and Meningoencephalitis, Southern India. Emerg Infect Dis. 2023;29(4):711-722. doi: 10.3201/eid2904.221157

    Singh B, Lant S, Cividini S, et al. Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis. PLoS One. 2022;17(6):e0263595. doi:10.1371/journal.pone.0263595

    Perry RJ, Tamborska A, Singh B, et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet. 2021: S0140-6736(21)01608-1. doi: 10.1016/S0140-6736(21)01608-1.

    Singh B, Ryan H, Kredo T, et al. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Cochrane Database Syst Rev . 2021;2:CD013587. doi: 10.1002/14651858.CD013587.pub2.

    Ellul M, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol 2020:19(9):767-783. doi: 10.1016/S1474-4422(20)30221-0.